Palvella Therapeutics
Develops topical QTORIN candidates for serious rare skin diseases and vascular malformations.
$149.97
After-hours close0.00 (0.00%)
At close$149.97(−0.24%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 110.29%Insiders 1.78%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 14.34M · Float 9.62M · 67.1% free float
Institutions13F, as of Jun 30, 2026
208 holders · 15.82M shares · 41 new positions · 129 increased · 43 reduced · 23 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 1.14M | 7.92% | −18.1K | Aug 14, 2026 |
| Jennison Associates LLC | 960.6K | 6.70% | +320.0K | Aug 3, 2026 |
| BlackRock, Inc. | 918.4K | 6.40% | +231.5K | Aug 7, 2026 |
| Frazier Life Sciences Management, L.P. | 882.4K | 6.15% | 0 | Aug 14, 2026 |
| First Light Asset Management, LLC | 771.9K | 5.38% | −208.9K | Aug 14, 2026 |
| BVF Inc/IL | 672.8K | 4.69% | −288.2K | Aug 14, 2026 |
| State Street Corp | 653.2K | 4.55% | +194.2K | Aug 7, 2026 |
| Price T Rowe Associates Inc /MD/ | 638.9K | 4.45% | +236.3K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| First Light Asset Management, LLC | 7.49% | 887.0K | 13G | Feb 17, 2026 ↗ |
| Suvretta Capital Management, LLC | 7.40% | 822.4K | 13G | Nov 13, 2025 ↗ |
| Prudential Financial Inc | 6.70% | 962.4K | 13G | Aug 10, 2026 ↗ |
| Jennison Associates LLC | 6.70% | 960.6K | 13G | Aug 3, 2026 ↗ |
| Frazier Life Sciences Public Fund, L.P. | 6.00% | 706.4K | 13G | Feb 13, 2026 ↗ |
| BlackRock, Inc. | 5.70% | 813.0K | 13G | Jul 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| George M. Jenkins | director | 201.1K | 1.40% | Apr 1, 2026 |
| Elaine J. Heron | director | 53.7K | 0.37% | Mar 2, 2026 |
| Matthew E. Korenberg | officer: CFO, Treasurer | 1.0K | 0.01% | Jun 16, 2026 |
3 people have not refiled in the last 18 months (977.3K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 5 lots | 4,302 | $152.21 | 0 |
| Jul 15, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 4 lots | 4,302 | $149.28 | 0 |
| Jun 17, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 3 lots | 4,302 | $110.73 | 0 |
| May 20, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 3 lots | 4,302 | $110.56 | 0 |
| Apr 15, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 5 lots | 4,302 | $127.24 | 0 |
| Mar 30, 2026 | George M. Jenkinsdirector | Purchase | 445 | $112.30 | 187,616 |
| Mar 18, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 3 lots | 4,302 | $117.99 | 0 |
| Feb 27, 2026 | Elaine J. Herondirector | Purchase | 2,400 | $125.00 | 47,812 |
| Feb 27, 2026 | George M. Jenkinsdirector | Purchase | 4,000 | $125.00 | 187,171 |
| Feb 18, 2026 | Kathleen Goinofficer: Chief Operating Officer | Sale · 2 lots | 4,302 | $79.40 | 0 |
CongressHouse and Senate disclosures
Not reported.